Raute Corporation: Inside information, profit warning: Raute updates its guidance - Comparable EBITDA will remain in line with the previous guidance, although net sales will be ...

Raute Corporation, Stock exchange release, Inside information, April 30, 2026, at 10:55 a.m. EEST Inside information, profit warning: Raute updates its guidance - Comparable EBITDA will remain in line ...

Viaplay Group AB: Viaplay Group to show UEFA Club competitions in Denmark, Norway and Finland until 2031

Viaplay Group has extended its exclusive rights to men's UEFA Champions League football in Denmark, and the exclusive rights to the UEFA Europa League and UEFA Conference League in Norway and Finland, ...

Integrum AB: Integrum implements a write-down of approximately SEK 7 million following reclassification of certain inventory items

Mölndal, Sweden, April 30, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that, as part of preparing the annual financial statements for the 2025/2026 fiscal yea ...

Summa Defence Oyj: Inside information: Summa Defence Plc's subsidiary IntLog Oy selected as a supplier for rescue container deliveries to the Finnish Defence Forces and county ...

April 2026 at 9:15 p.m. EEST Summa Defence Plc's subsidiary IntLog Oy has been selected as supplier in a public procurement decision by the Finnish Defence ...

Trulieve Cannabis Corp.: Trulieve Announces Applications Filed for DEA Registration of State Licensed Medical Marijuana Businesses

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis ...

Neurocrine Biosciences, Inc.: Neurocrine Biosciences Announces Publication Establishing Clinically Meaningful Improvement Threshold for the Tardive Dyskinesia Impact Scale

Research published in The Journal of Clinical Psychiatry characterizes patient-reported improvement with INGREZZA® (valbenazine) capsules across the KINECT® clinical ...

O'Reilly Automotive, Inc. Reports First Quarter 2026 Results

First quarter comparable store sales growth of 8.1%16% increase in first quarter diluted earnings per share to $0.72$1 billion net cash provided by operating activities year-to-date SPRINGFIELD, Mo., ...

AlzeCure Pharma AB: Adjusted timeline for the previously communicated rights issue

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, announces that the time ...

International Personal Finance plc.: Q1 2026 Trading Update

April 2026 International Personal Finance plc Q1 2026 trading update A positive start to 2026 International Personal Finance plc ("IPF" or the "Group") is helping to build a better world through ...

Xbrane Biopharma AB: Xbrane Submits Ranibizumab Biosimilar Candidate To FDA

Xbrane Biopharma AB (Nasdaq Stockholm: XBRANE) has submitted an application for approval (BLA) to the U.S. Food and Drug Administration for its biosimilar candidate to LUCENTIS (ranibizumab). The orig ...

ROCTOOL: Trexel and Roctool announce global lightweighting alliance

DJ Trexel and Roctool announce global lightweighting alliance ROCTOOL Trexel and Roctool announce global lightweighting alliance 29-Apr-2026 / 18:00 CET/CEST Dissemination of a French Regulatory ...

Q-Linea AB: Interim report January - March 2026

Growing recurring income and increased market activity within rapid AST First quarter: 1 January-31 March 2026Income from sales of consumables amounted to SEK 1.4 (0.9) million, an increase of approx.